Cellular therapies in lymphoma bring hope, but optimizing their use remains a challenge American Journal of Managed Care08:14Cancer Cancer Treatment T-Cells

New method to classify paediatric all British Society for Haematology04:45Leukaemia

Robust chromatin map explains heterogeneity of paediatric acute lymphoblastic leukaemia ecancer10:43Leukaemia

Latest News

In the last 5 minutes

Pirtobrutinib Demonstrates Durable Efficacy in Covalent BTK Inhibitor–Pretreated CLL/SLL OncLive11:27

Zanubrutinib Showcases Sustained PFS Benefit Vs Ibrutinib in R/R CLL/SLL OncLive11:27

In the last half-hour

Golidocitinib Demonstrates Significant Survival Benefits For Patients with Peripheral T-cell Lymphoma Pharmacy Times11:12

In the last 4 hours

Cellular Therapies in Lymphoma Bring Hope, But Optimizing Their Use Remains a Challenge American Journal of Managed Care08:14

Earlier today

Assessing Clinical Trial Efficacy Vs Real-World Effectiveness in the Treatment of Multiple Myeloma Pharmacy Times02:42

Yesterday

Ide-Cel Provides HRQOL Benefits Over Standard Regimens in R/R Multiple Myeloma OncLive18:51 9-Dec-23

Bridging Therapy Prior to Axi-Cel Produces Favorable Real-World Outcomes in R/R LBCL OncLive18:41 9-Dec-23

Real-World Analysis Sheds Light on Safety and Efficacy of Teclistamab in R/R Multiple Myeloma OncLive18:30 9-Dec-23

Tislelizumab plus zanubrutinib for Richter transformation: the phase 2 RT1 trial Nature.com18:11 9-Dec-23

Brexu-Cel Induces Responses in Real-World Population of High-Risk R/R MCL OncLive17:59 9-Dec-23

New Hybrid Treatment Forces Cancer Cells to Starve PR Newswire (Press Release)15:04 9-Dec-23

STAT Plus: Was CAR-T therapy a bystander or driver of lymphoma? Researchers examine first… STAT12:36 9-Dec-23

Scenic Biotech Announces Positive Preclinical Data for its QPCTL Inhibitor SC-2882 as Potential … Business Wire (Press Release)12:35 9-Dec-23

Gilead and Kite Oncology Present Data Demonstrating CAR T-cell Therapy Survival Benefit and Showcasing Latest Advances… Gilead Sciences (Press Release)12:33 9-Dec-23

New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients… AbbVie (Press Release)12:06 9-Dec-23

New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High… Business Wire (Press Release)12:04 9-Dec-23

Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in… GlobeNewswire (Press Release)08:37 9-Dec-23

In the last 7 days

Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA (anito-cel) Phase 1 … PR Newswire (Press Release)16:00 8-Dec-23

Real-World Data Show Poor Outcomes Among Patients With ACS and Blood Cancers American Journal of Managed Care15:11 8-Dec-23

Health Care Resource Use, Cost Burden Appear Substantial in R/R B-Cell ALL American Journal of Managed Care14:51 8-Dec-23

Vittoria’s CAR-T therapy secures clinical approval amid FDA scrutiny on sector Pharmaceutical Technology12:37 8-Dec-23

Ian Hensley Coast2Coast Walk for Myeloma UK Northampton Chronicle & Echo11:37 8-Dec-23

Pfizer’s multiple myeloma treatment secures conditional approval in EU Pharmaceutical Technology11:05 8-Dec-23

Blood cancer patients to receive home from home accommodation in Blackpool Blackpool Teaching Hospitals NHS Foundation Trust (Press Release)11:01 8-Dec-23

Varicose veins could be a sign of Cancer, doctors warn - after treating 53-year-old woman with… Mail Online10:38 8-Dec-23

Amgen Highlights Hematology Portfolio At Ash 2023 PR Newswire (Press Release)09:01 8-Dec-23

European Commission Approves Pfizer’s ELREXFIO® for Relapsed and Refractory Multiple Myeloma Pfizer (Press Release)08:00 8-Dec-23

Sanofi’s Phase III multiple myeloma trial meets primary goal Clinical Trials Arena06:10 8-Dec-23

Blood Cancer Drugs Market is projected to witness lucrative growth by reaching up to USD 113.5… Industry Today04:32 8-Dec-23

Roche's double-antibody DLBCL treatment Columvi nabs Korean nod Korea Biomedical Review01:54 8-Dec-23

Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple… Nature.com01:50 8-Dec-23

Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity Nature.com18:20 7-Dec-23

Yousaf pushed on Glasgow health board decision to scrap Oban blood cancer specialist The Scottish Herald11:49 7-Dec-23

Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera to Be… Business Wire (Press Release)10:59 7-Dec-23

Mission Bio Announces Over 20 Presentations Demonstrating the Utility of Tapestri Across AML,… Business Wire (Press Release)08:17 7-Dec-23

Updated Linvoseltamab Pivotal Data Demonstrated Strong Rates and Depth of Response in Patients with Heavily Pre-Treated … GlobeNewswire (Press Release)07:04 7-Dec-23

STAT Plus: ‘Learning each other’s language’: FDA, patent office seek to work together to lower… STAT04:37 7-Dec-23

Press Release: Sarclisa® (isatuximab) Phase 3 trial met primary endpoint of progression free survival in patients with… GlobeNewswire (Press Release)01:40 7-Dec-23

Sample average treatment effect on the treated (SATT) analysis using counterfactual explanation identifies BMT and… Nature.com23:24 6-Dec-23

IGM jettisons workforce and blood cancer programme to refocus pipeline Pharmaceutical Technology13:15 6-Dec-23

St. Jude research featured at the American Society of Hematology Annual Meeting Newswise (Press Release)10:48 6-Dec-23

Glyphosate, the active ingredient in the weedkiller Roundup, is showing up in pregnant women living near farm fields –… The Conversation (US)08:30 6-Dec-23

Haematology team win top award for care Cambridge University Hospitals (Press Release)04:09 6-Dec-23

Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL Medpage Today01:32 6-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Primary CNS Lymphoma: Likelihood of… Pharmaceutical Technology21:48 5-Dec-23

Linvoseltamab by Regeneron Pharmaceuticals for Multiple Myeloma (Kahler Disease): Likelihood of … Pharmaceutical Technology21:28 5-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Extranodal Marginal Zone B-Cell Lymphoma… Pharmaceutical Technology20:47 5-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Nodal Marginal Zone B-Cell Lymphoma:… Pharmaceutical Technology20:47 5-Dec-23

AGENT-797 by MiNK Therapeutics for Refractory Multiple Myeloma: Likelihood of Approval Pharmaceutical Technology20:26 5-Dec-23

ZND-5 by Zentalis Pharmaceuticals for Non-Hodgkin Lymphoma: Likelihood of Approval Pharmaceutical Technology20:26 5-Dec-23

US drug shortages are forcing ‘impossible choices’ for Americans, experts tell Senate committee CNN18:27 5-Dec-23

Air Force expands deadly cancer study at secret underground nuclear missile sites after cluster … Mail Online13:23 5-Dec-23

Pacmilimab by CytomX Therapeutics for Lymphoma: Likelihood of Approval Pharmaceutical Technology13:18 5-Dec-23

Tazemetostat hydrobromide by Ipsen for Mantle Cell Lymphoma: Likelihood of Approval Pharmaceutical Technology13:08 5-Dec-23

Tazemetostat hydrobromide by Ipsen for Diffuse Large B-Cell Lymphoma: Likelihood of Approval Pharmaceutical Technology13:08 5-Dec-23

Leukaemia cells activate cellular recycling program ecancer11:02 5-Dec-23

The Leukemia & Lymphoma Society (LLS) Data and Presence at ASH Showcase Latest Blood Cancer… PR Newswire (Press Release)08:01 5-Dec-23

Non-Covalent BTK Inhibitor Approved for CLL Medpage Today01:36 5-Dec-23

Modakafusp alfa by Millennium Pharmaceuticals for Refractory Multiple Myeloma: Likelihood of… Pharmaceutical Technology00:53 5-Dec-23

ISB-2001 by Ichnos Sciences for Refractory Multiple Myeloma: Likelihood of Approval Pharmaceutical Technology00:12 5-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Marginal Zone B-cell Lymphoma: Likelihood… Pharmaceutical Technology00:02 5-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Secondary CNS Lymphoma: Likelihood of… Pharmaceutical Technology00:02 5-Dec-23

Lisocabtagene maraleucel by Bristol-Myers Squibb for Mantle Cell Lymphoma: Likelihood of… Pharmaceutical Technology00:02 5-Dec-23

Bis-5 by L&L Biopharma for Lymphoma: Likelihood of Approval Pharmaceutical Technology23:21 4-Dec-23

MB-106 by Mustang Bio for Waldenstrom Macroglobulinemia (Lymphoplasmacytic Lymphoma):… Pharmaceutical Technology22:41 4-Dec-23

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) drugs in development, 2023 Pharmaceutical Technology20:58 4-Dec-23

Amdizalisib by Hutchison MediPharma for Nodal Marginal Zone B-Cell Lymphoma: Likelihood of… Pharmaceutical Technology20:48 4-Dec-23

Scientists unmask molecule that fuels leukemia growth News-Medical.Net19:27 4-Dec-23

FDA Grants Orphan Drug Designation to LP-284 for High-Grade B-Cell Lymphomas OncLive18:49 4-Dec-23

Leukemia cells activate cellular recycling program Newswise (Press Release)18:06 4-Dec-23

Scientists uncover new mechanism by which leukemia cells exploit cellular recycling process News-Medical.Net13:20 4-Dec-23

CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple… PR Newswire (Press Release)08:52 4-Dec-23

YTHDF2's Role in Promoting Acute Myeloid Leukemia: The Key Lies in microRNA Processing Newswise (Press Release)08:51 4-Dec-23

K36 Therapeutics Announces Presentation on KTX-1001 for Relapsed and Refractory Multiple… PR Newswire (Press Release)08:00 4-Dec-23

Eli Lilly’s Jaypirca granted FDA accelerated approval for non-Hodgkin lymphomas PMLiVE07:41 4-Dec-23

Eli Lilly Receive Second FDA Approval For Blood Cancer Drug European Pharmaceutical Manufacturer04:13 4-Dec-23

Mum of little Scots girl diagnosed with cancer tells others 'you are not alone' Daily Record06:04 3-Dec-23

In the last month

FCS Launches Advanced Cellular Therapy Program to Treat Recurring Blood Cancers OncLive08:18 2-Dec-23

Year in Review: Follicular Lymphoma Medpage Today01:31 2-Dec-23

US FDA gives second approval to Eli Lilly's drug for type of blood cancer Reuters18:23 1-Dec-23

FDA Approves Pirtobrutinib for Previously Treated CLL/SLL OncLive18:05 1-Dec-23

"HyBryte™ Use in Early-Stage Cutaneous T-Cell Lymphoma" Published in Frontiers in Drug Discovery PR Newswire (Press Release)07:31 1-Dec-23

FDA warns breakthrough cancer treatment might cause cancer ConsumerAffairs.Com07:15 1-Dec-23

New method to classify paediatric ALL British Society for Haematology04:45 1-Dec-23

Study Finds ASCT Similarly Safe, Effective in Older and Younger Patients With Multiple Myeloma American Journal of Managed Care17:08 30-Nov-23

FDA warns certain therapy to treat cancer may cause secondary cancer Scripps News14:42 30-Nov-23

Fred Hutch at ASH: Gene therapies for sickle cell, how to improve ‘time toxicity’ for multiple myeloma treatments, what … Fred Hutchinson Cancer Research Center (Press Release)14:27 30-Nov-23

FDA Grants Lantern Pharma Orphan Drug Designation For Drug Candidate LP-284 In High-Grade… Drugs Discovery Online08:00 30-Nov-23

Gene interaction network analysis in multiple myeloma detects complex immune dysregulation associated with shorter… Nature.com22:10 29-Nov-23

Belantamab Mafodotin Improves PFS in Relapsed/Refractory Multiple Myeloma American Journal of Managed Care19:08 29-Nov-23

Belantamab Mafodotin Met Primary Endpoint for Those with Relapsed, Refractory Multiple Myeloma Pharmacy Times11:53 29-Nov-23

STAT Plus: Pharmalittle: FDA probes CAR-T therapy for links to lymphoma; White House official… STAT09:11 29-Nov-23

Johnson & Johnson highlights its preeminent leadership in hematology through differentiated blood cancer portfolio and… Johnson & Johnson (Press Release)09:01 29-Nov-23

Matilda the Brave: Castleford family share their story following tot's acute lymphoblastic… Wakefield Express14:00 28-Nov-23

STAT Plus: FDA investigating whether CAR-T, a treatment for cancer, can also cause lymphoma STAT13:52 28-Nov-23

FDA Grants Breakthrough Therapy Designation to Epcoritamab for Follicular Lymphoma Pharmacy Times10:16 28-Nov-23

Rutgers Cancer Institute of New Jersey and RWJBarnabas Health to Showcase Expansive Portfolio of Hematology/Oncology… Newswise (Press Release)09:29 28-Nov-23

GSK shares positive phase 3 results for Blenrep combination in multiple myeloma PMLiVE07:41 28-Nov-23

NGeneBio's blood cancer diagnostic panel gets permit in Thailand Korea Biomedical Review01:23 28-Nov-23

RNA-based therapy shows promise for treating leukemia in animal models News-Medical.Net20:47 27-Nov-23

Boost for GSK as blood cancer drug Blenrep hits key goal in a late-stage trial This is Money17:06 27-Nov-23

EMA Validates Application for Epcoritamab in Relapsed/Refractory Follicular Lymphoma OncLive16:02 27-Nov-23

FDA Approval Sought for Obe-Cel in Relapsed/Refractory B-ALL OncLive13:08 27-Nov-23

Belantamab Mafodotin Plus Bortezomib/Dexamethasone Improves PFS in R/R Multiple Myeloma OncLive13:08 27-Nov-23

AbbVie’s epcoritamab gets one step closer to follicular lymphoma approval Pharmaceutical Technology10:41 27-Nov-23

AbbVie Receive EMA and FDA Updates on Lymphoma Treatment European Pharmaceutical Manufacturer09:42 27-Nov-23

Ongoing Research Aims to Better Define Role of ASCT in Myeloma OncLive09:25 27-Nov-23

AbbVie Announces U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) Updates for Epcoritamab… AbbVie (Press Release)07:09 27-Nov-23

Genmab Announces Positive Regulatory Updates for Epcoritamab (EPKINLY®/TEPKINLY®) for the… Business Wire (Press Release)07:01 27-Nov-23

Is GSK’s Blenrep heading for a renaissance? pharmaphorum06:36 27-Nov-23

GSK reports positive data from Phase III multiple myeloma trial Clinical Trials Arena06:12 27-Nov-23

GSK shares results from phase 3 trial for Blenrep as multiple myeloma treatment Pharmafile05:46 27-Nov-23

GSK Blood Cancer Drug Blenrep Hits Goal in Late-Stage Trial European Pharmaceutical Manufacturer03:57 27-Nov-23

GSK announces positive results from DREAMM-7 head-to-head phase III trial for Blenrep in relapsed/refractory multiple… GlaxoSmithKline (Press Release)02:08 27-Nov-23

Innate Pharma to Host Virtual KOL Event on Lacutamab Business Wire (Press Release)01:05 27-Nov-23

view more headlines

10 Dec 11:27

Blood Cancer

Latest News

Cancer Top Stories

Health Top Stories

Lifestyle Top Stories